A new cancer treatment can wipe out tumours in terminally ill head and neck cancer patients, scientists have discovered.
Scientists found the combination of nivolumab and ipilimumab medications led to a reduction in the size of tumours in terminally ill head and neck cancer patients.
In some, their cancer vanished altogether, with doctors stunned to find no detectable sign of disease.
Combining the two immunotherapy drugs could prove an effective new weapon against several forms of advanced cancer, experts believe.
Results from other trials of the drug combination have previously suggested similar benefits for terminally ill kidney, skin and bowel cancer patients.
About 12,000 people in the UK are diagnosed with head and neck cancer every year and many will be diagnosed at advanced stages.
“We will need to do longer follow-up to see whether we can demonstrate a survival benefit across all patients in the trial. »
